Systemic immunosuppression in times of COVID-19: do we need to rethink our standards?

The current SARS-CoV-2 pandemic particularly endangers older people with pre-existing cardiopulmonary and metabolic conditions. However, it is also currently under discussion whether patients under immunosuppressive therapy also have a higher risk of suffering a severe course of the COVID-19 disease...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Grabbe, Stephan (Autore) , Beissert, Stefan (Autore) , Enk, Alexander (Autore)
Natura: Article (Journal)
Lingua:inglese
Pubblicazione: 21 August 2020
In: Journal der Deutschen Dermatologischen Gesellschaft
Year: 2020, Volume: 18, Fascicolo: 8, Pages: 810-813
ISSN:1610-0387
DOI:10.1111/ddg.14194
Accesso online:Verlag, kostenfrei, Volltext: https://doi.org/10.1111/ddg.14194
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/ddg.14194
Testo
Note sull'autore:Stephan Grabbe, Stefan Beissert, Alexander Enk